欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2006, Vol. 11 ›› Issue (6): 706-708.

• 研究原著 • 上一篇    下一篇

血管紧张素转换酶抑制剂联合血管紧张素II受体阻滞剂治疗糖尿病肾病的临床研究

栾旭   

  1. 大庆龙南医院肾内科, 大庆 163000, 黑龙江
  • 收稿日期:2006-03-13 修回日期:2006-05-28 出版日期:2006-06-26 发布日期:2020-12-04
  • 作者简介:栾旭,女,大学本科,副主任医师,研究方向:临床肾脏内科。Tel:13504658888 E-mail:luanxu6493@sina.com

Clinical observation and research of angiotensin converting enzyme inhibitor and angiotensin Ⅱ antagonist on diabetic renopathy

LUAN Xu   

  1. Department of Urinary Medicine, Longnan Hospital of Daqing, Daqing 163000, Heilongjiang, China
  • Received:2006-03-13 Revised:2006-05-28 Online:2006-06-26 Published:2020-12-04

摘要: 目的: 观察血管紧张素转换酶抑制剂(ACEI)联合血管紧张素II 受体阻滞剂(ARB) 治疗糖尿病肾病是否优于单独用药治疗, 以探讨治疗糖尿病肾病更有效的治疗方法。方法: 筛选72 名病人, 建立3个观察组:ACEI 组(ACEI 代表药物为蒙诺)、ARB 组(ARB 代表药物为代文)、ACEI+ARB 组(蒙诺联合代文);疗程8 周, 治疗前后检测24 h 尿蛋白定量。结果: 3 个治疗组治疗前尿蛋白定量无统计学差异(P>0.05), 具有可比性;每个治疗组治疗后24 h 尿蛋白定量减少;与单独用药组相比, 联合用药组尿蛋白显著降低。结论: 无论是单用蒙诺或代文, 还是联合蒙诺及代文, 均可有效降低尿蛋白;蒙诺组与代文组治疗效果相当。而联合用药组治疗效果明显优于单独用药组。

关键词: 血管紧张素转化酶抑制剂, 血管紧张素受体Ⅱ拮抗剂, 糖尿病肾病, 24 小时尿蛋白定量

Abstract: AIM: Tofind out a more effective therapy to cure diabetic renopathy through observing whether combination of angiotensin converting enzyme inhibitor (ACEI) and angiotensin Ⅱ antagonist (ARB) treatment is more effective than that of using single medicine.Methods: Seventy-two selected patients were divided into three groups in which are ACEI group (representative medicine is monopril, ARB group (representative medicine is valsartan) and ACEI+ARB group (representative medicines are monopril and valsartan.The period of treatment is 8 weeks.The 24-hour uric albumen examination was detected before and after the treatment.Results: No significant difference showed before the treatment (P>0.05).There was significant difference in the decrease of the amount of 24-hour urine protein examination before and after the treatment among three groups.Compared with the single drug group, the effects of the combination group was better.Conclusion: Using monopril or valsartan solely or the combination of monopril and valsartan can decrease the 24-hour urine protein effectively. The effect of monopril and valsartan are same.However, the effect of the combination group was better than the two single drug groups.

Key words: angiotensin converting enzyme inhibitor, angiotensin Ⅱantagonist, diabetic renopathy, 24-hour urine protein examination

中图分类号: